Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 29, 2022, Vyant Bio, Inc. (the "Company") terminated the employment contract of Ralf Brandt, Ph.D. effective December 31, 2022. Dr. Brandt was the President of Discovery & Early Development Services of the Company which included the Company's Hershey, Pennsylvania based subsidiary, vivoPharm, LLC, which was sold by the Company to Reaction Biology Corporation on November 2, 2022. Dr. Brandt will be entitled to such benefits as are provided for in his August 14, 2017 employment agreement.

© Edgar Online, source Glimpses